nach oben

Erschienen in:

29.11.2023 | Review

Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis

verfasst von: Jeremiah H. Wijaya, Utsav D. Patel, Miguel D. Quintero-Consuegra, Maria P. Aguilera-Peña, Humberto J. Madriñán-Navia, Aulia W. Putra, Julius July, Saurabh Kataria

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The blood-brain barrier can prevent circulating tumor DNA (ctDNA) derived from the central nervous system from entering the blood making it challenging to evaluate molecular features of leptomeningeal metastasis (LM). Accordingly, we sought to systematically compare the diagnostic power or significance of ctDNA derived from cerebrospinal fluid (CSF) compared to plasma ctDNA in patients with LM.

Methods

A systematic review and meta-analysis was performed under the PRISMA guideline. We used PubMed, EMBASE, and the EuroPMC to search the literature using combinations of the following terms: circulating tumor DNA, ctDNA, circulating tumor cell, brain metastasis, leptomeningeal metastasis, outcome(s), and prognosis. We included all available English language studies that compared the diagnostic significance of CSF derived and serum ctDNA. All eligible studies level of bias was assessed using the New Castle Ottawa Scale (NOS).

Results

Our meta-analysis from 6 included studies (n = 226) that confirmed the diagnostic power of liquid biopsies in detecting genomic alteration is better when taking a CSF-derived samples than from the plasma (RR 1.46 [0.93; 2.29]; I² = 92%; p-value < 0.01).

Conclusion

CSF ctDNA is better at describing molecular landscape for LM; such an understanding may ultimately help inform patient treatment and responses to therapy.

Valiente M, Ahluwalia MS, Boire A et al (2018) The Evolving Landscape of Brain Metastasis. Trends Cancer 4:176–196. https://doi.org/10.1016/j.trecan.2018.01.003CrossRefPubMedPubMedCentral

Choi W, Cho Y, Park S-Y et al (2021) A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis. J Cancer Res Clin Oncol 147:213–222. https://doi.org/10.1007/s00432-020-03324-5CrossRefPubMed

Xu Q, Ye L, Huang L et al (2021) Serum exosomal miRNA might be a Novel Liquid Biopsy to identify Leptomeningeal Metastasis in Non-small Cell Lung Cancer. OTT Volume 14:2327–2335. https://doi.org/10.2147/OTT.S291611CrossRef

Xu Y, Hu M, Zhang M et al (2018) Prospective study revealed prognostic significance of responses in leptomeningeal Metastasis and clinical value of cerebrospinal fluid-based liquid biopsy. Lung Cancer 125:142–149. https://doi.org/10.1016/j.lungcan.2018.08.017CrossRefPubMed

Lim C, Tsao MS, Le LW et al (2015) Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell Lung cancer. Ann Oncol 26:1415–1421. https://doi.org/10.1093/annonc/mdv208CrossRefPubMed

Rolfo C, Mack P, Scagliotti GV et al (2021) Liquid Biopsy for Advanced NSCLC: a Consensus Statement from the International Association for the study of Lung Cancer. J Thorac Oncol 16:1647–1662. https://doi.org/10.1016/j.jtho.2021.06.017CrossRefPubMed

Bhambhvani HP, Rodrigues AJ, Umeh-Garcia MC, Hayden Gephart M (2020) Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and emerging therapies. Neurosurg Clin N Am 31:613–625. https://doi.org/10.1016/j.nec.2020.06.010CrossRefPubMedPubMedCentral

Anwar A, Gudlavalleti A, Ramadas P (2023) Carcinomatous Meningitis. In: StatPearls. StatPearls Publishing, Treasure Island (FL)

Batool A, Kasi A (2023) Leptomeningeal Carcinomatosis. In: StatPearls. StatPearls Publishing, Treasure Island (FL)

10.

Cescon DW, Bratman SV, Chan SM, Siu LL (2020) Circulating Tumor DNA and liquid biopsy in oncology. Nat Cancer 1:276–290. https://doi.org/10.1038/s43018-020-0043-5CrossRefPubMed

11.

Heitzer E, Ulz P, Geigl JB (2015) Circulating Tumor DNA as a liquid biopsy for cancer. Clin Chem 61:112–123. https://doi.org/10.1373/clinchem.2014.222679CrossRefPubMed

12.

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

13.

Chen X, Bai K, Zhang Y et al (2023) Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer. J Transl Med 21:296. https://doi.org/10.1186/s12967-023-04077-8CrossRefPubMedPubMedCentral

14.

Di W-Y, Chen Y-N, Cai Y et al (2023) The diagnostic significance of cerebrospinal fluid cytology and circulating Tumor DNA in meningeal carcinomatosis. Front Neurol 14:1076310. https://doi.org/10.3389/fneur.2023.1076310CrossRefPubMedPubMedCentral

15.

Fitzpatrick A, Iravani M, Mills A et al (2022) Assessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in Breast Cancer Leptomeningeal Metastasis. Clin Cancer Res 28:1180–1191. https://doi.org/10.1158/1078-0432.CCR-21-3017CrossRefPubMedPubMedCentral

16.

Wu J, Liu Z, Huang T et al (2023) Cerebrospinal fluid circulating Tumor DNA depicts profiling of brain Metastasis in NSCLC. Mol Oncol 17:810–824. https://doi.org/10.1002/1878-0261.13357CrossRefPubMed

17.

Li M, Chen J, Zhang B et al (2023) Correction: dynamic monitoring of cerebrospinal fluid circulating Tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial Tumor responses in non-small cell Lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028). BMC Med 21:15. https://doi.org/10.1186/s12916-022-02718-1CrossRefPubMedPubMedCentral

18.

Ma C, Yang X, Xing W et al (2020) Detection of circulating Tumor DNA from non-small cell Lung cancer brain Metastasis in cerebrospinal fluid samples. Thorac Cancer 11:588–593. https://doi.org/10.1111/1759-7714.13300CrossRefPubMedPubMedCentral

19.

Rehman AU, Khan P, Maurya SK et al (2022) Liquid biopsies to occult brain Metastasis. Mol Cancer 21:113. https://doi.org/10.1186/s12943-022-01577-xCrossRefPubMedPubMedCentral

20.

Shtivelman E, Hensing T, Simon GR et al (2014) Molecular pathways and therapeutic targets in Lung cancer. Oncotarget 5:1392–1433. https://doi.org/10.18632/oncotarget.1891CrossRefPubMedPubMedCentral

21.

Dar KB, Bhat AH, Amin S et al (2019) Exploring proteomic drug targets, therapeutic strategies and protein - protein interactions in Cancer: mechanistic view. Curr Cancer Drug Targets 19:430–448. https://doi.org/10.2174/1568009618666180803104631CrossRefPubMed

22.

De Mattos-Arruda L, Mayor R, Ng CKY et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6:8839. https://doi.org/10.1038/ncomms9839CrossRefPubMedPubMedCentral

23.

Sun H, Liu S-Y, Zhou J-Y et al (2020) Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma. EBioMedicine 60:102990. https://doi.org/10.1016/j.ebiom.2020.102990CrossRefPubMedPubMedCentral

24.

Escudero L, Llort A, Arias A et al (2020) Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma. Nat Commun 11:5376. https://doi.org/10.1038/s41467-020-19175-0CrossRefPubMedPubMedCentral

25.

Escudero L, Martínez-Ricarte F, Seoane J (2021) ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer. Cancers (Basel) 13:1989. https://doi.org/10.3390/cancers13091989CrossRefPubMed

Titel: Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis
verfasst von: Jeremiah H. Wijaya
Utsav D. Patel
Miguel D. Quintero-Consuegra
Maria P. Aguilera-Peña
Humberto J. Madriñán-Navia
Aulia W. Putra
Julius July
Saurabh Kataria
Publikationsdatum: 29.11.2023
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2023
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-023-04519-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2023

Preoperative assessment of eloquence in neurosurgery: a systematic review

Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study

Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow

Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients

Incidental meningiomas: a current and increasingly common challenge